RICONPHARMA LLC FDA Approval ANDA 216275

ANDA 216275

RICONPHARMA LLC

FDA Drug Application

Application #216275

Application Sponsors

ANDA 216275RICONPHARMA LLC

Marketing Status

Prescription001

Application Products

001TABLET, EXTENDED RELEASE;ORAL100MG0DICLOFENAC SODIUMDICLOFENAC SODIUM

FDA Submissions

UNKNOWN; ORIG1AP2022-09-23STANDARD

Submissions Property Types

ORIG1Null15

TE Codes

001PrescriptionAB

CDER Filings

RICONPHARMA LLC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 216275
            [companyName] => RICONPHARMA LLC
            [docInserts] => ["",""]
            [products] => [{"drugName":"DICLOFENAC SODIUM","activeIngredients":"DICLOFENAC SODIUM","strength":"100MG","dosageForm":"TABLET, EXTENDED RELEASE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"09\/23\/2022","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2022-09-23
        )

)

© 2022 FDA.report
This site is not affiliated with or endorsed by the FDA.